Biotech · Private company
Takara Bio Inc.
Track this companyFree. Adds Takara Bio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- HF10Phase 1 · Refractory Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a MelanomaPHASE2 · TERMINATED · started Jan 3, 2018ClinicalTrials.gov NCT03259425 · fetched Nov 12, 2026
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial LesionsPHASE1 · COMPLETED · started Aug 1, 2009ClinicalTrials.gov NCT01017185 · fetched Nov 12, 2026